Maximize Your Impact At PEGS Europe 2025
PEGS Europe 2025, taking place from November 11–14 at the Lisbon Congress Centre in Lisbon, Portugal, is one of the industry’s leading forums for protein science and biotherapeutics R&D. Attendees include senior scientists, pharmaceutical executives, biotech founders, and research leaders who are shaping the future of drug discovery and development. This event is known for catalyzing critical decisions around bioprocessing strategies, therapeutic pipeline collaborations, and technology sourcing.
R&D-focused budgets, licensing partnerships, and platform evaluations are actively discussed here, making it a priority event for those seeking high-value scientific and commercial engagements. Attendee participation spans global pharma companies, emerging biotech firms, academic institutions, and solution providers. With Vendelux’s enriched attendee list, teams can identify key stakeholders early—scientific leads, business development managers, and innovation scouts—well before they arrive in Lisbon.
How Sales, Marketing and Revops Teams Can Use This Attendee List
For commercial teams targeting biotech and pharma innovation leaders, the enriched attendee list from PEGS Europe 2025 offers a way to plan outreach with accuracy and depth. Use attendee data to segment contacts based on therapeutic area focus, functional responsibility, or company size. This enables targeted engagement strategies whether you’re introducing a new bioprocessing platform or scouting for co-development partners.
Sellers can focus on getting conversations started pre-conference with decision-makers responsible for technology evaluations and scale-up initiatives. Marketers can use the attendee information to craft messaging aligned to specific protein engineering or cell therapy tracks. Having access to verified emails and titles helps secure qualified meetings, while the context around each attendee’s role supports more relevant follow-ups after the event. By using Vendelux’s enriched conference attendee list, teams are better positioned to get more meetings and build long-term relationships with conference attendees.
Timing Is Everything
PEGS Europe 2025 is scheduled for November 11–14, 2025. With over six months remaining, now is the ideal time to begin strategic outreach using Vendelux to gain visibility into who is planning to attend. Early contact increases the chances of scheduling time with program leads and sourcing managers before their calendars fill.
Using the attendee list, target accounts can be filtered and prioritized for engagement that aligns with their investment cycles, therapeutic interests, or legacy partnerships. This head start creates space for authentic pre-event conversations that lead to more productive meetings on site in Lisbon.
What’s Included In The PEGS Europe 2025 Attendee List?
Vendelux provides visibility into executives, researchers, and commercial leaders expected to attend PEGS Europe 2025 through a combination of organizer-sourced data and predictive insights. Clients can upload a target account list to identify confirmed and likely matches in the attendee population.
The enriched list includes full names, job titles, company names, company websites, physical locations (city, state, country), LinkedIn profiles, verified email addresses, and phone numbers when available.
Where Is PEGS Europe 2025?
The event takes place at the Lisbon Congress Centre in Lisbon, Lisboa, Portugal.
When Is PEGS Europe 2025?
PEGS Europe 2025 will be held from November 11–14, 2025.
What Type Of Event Is PEGS Europe 2025?
PEGS Europe is a scientific and business-driven conference focused on protein and antibody engineering, immunotherapy, cell therapy, and biologics development. The event includes plenary sessions, technical tracks, keynote addresses, breakout panels, and high-value networking designed to connect innovators and decision-makers in pharmaceutical R&D.
How Many People Attend PEGS Europe 2025?
PEGS Europe 2025 is expected to draw over 1,500 attendees from more than 40 countries. The audience includes scientific leaders, senior-level executives, business development professionals, and technical strategists across the biopharma and life sciences sectors.
